Terms: = Head and neck cancer AND uPA
179 results:
1. Prognostic evaluation of oral squamous cell carcinoma based on pleiotrophin, urokinase plasminogen activator, and glycoprotein nonmetastatic melanoma protein B expression.
Ma Y; Liu Y; Meng H
Medicine (Baltimore); 2023 Nov; 102(45):e35634. PubMed ID: 37960806
[TBL] [Abstract] [Full Text] [Related]
2. Ulinastatin inhibits the metastasis of nasopharyngeal carcinoma by involving upa/upaR signaling.
Li CZ; Qiang YY; Liu ZJ; Zheng LS; Peng LX; Mei Y; Meng DF; Wei WW; Chen DW; Xu L; Lang YH; Xie P; Peng XS; Wang MD; Guo LL; Shu DT; Ding LY; Lin ST; Luo FF; Wang J; Li SS; Huang BJ; Chen JD; Qian CN
Drug Dev Res; 2023 Nov; 84(7):1468-1481. PubMed ID: 37534761
[TBL] [Abstract] [Full Text] [Related]
3. The coagulome of oral squamous cell carcinoma: examining the role and regulation of coagulation in oral cancers using a systems approach.
Racine F; Soudet S; Sevestre MA; Galmiche A; Saidak Z
Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):73-77. PubMed ID: 36912218
[TBL] [Abstract] [Full Text] [Related]
4. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract] [Full Text] [Related]
5. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
[TBL] [Abstract] [Full Text] [Related]
6. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M
J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253
[TBL] [Abstract] [Full Text] [Related]
7. Salivary KLK5 and upa are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract] [Full Text] [Related]
8. Role of IGFBP-2 in oral cancer metastasis.
Tsai YF; Chou HC; Liou MH; Liao EC; Cheng CT; Chang SJ; Chan HL
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166143. PubMed ID: 33864954
[TBL] [Abstract] [Full Text] [Related]
9. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
Son SH; Park J; Jung MJ; Lee SK; Kim H; Kim KR; Park KK; Chung WY
Eur J Oral Sci; 2021 Feb; 129(1):e12750. PubMed ID: 33503283
[TBL] [Abstract] [Full Text] [Related]
10. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.
Peng X; Liu Y; Zhu S; Peng X; Li H; Jiao W; Lin P; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2921-2936. PubMed ID: 31620898
[TBL] [Abstract] [Full Text] [Related]
11. Knockdown of Notch1 inhibits nasopharyngeal carcinoma cell growth and metastasis via downregulation of CCL2, CXCL16, and upa.
Guo H; Wang F; Diao Y; Zhang Z; Chen Q; Qian CN; Keller ET; Zhang J; Lu Y
Mol Carcinog; 2019 Oct; 58(10):1886-1896. PubMed ID: 31270884
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.
Cui Z; Sun S; Liu Q; Zhou X; Gao S; Peng P; Li Q
Biochem Cell Biol; 2020 Apr; 98(2):154-163. PubMed ID: 31265790
[TBL] [Abstract] [Full Text] [Related]
13. Sentinel Lymph Node-Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of head and neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model.
Tanaka Y; Araki K; Tanaka S; Miyagawa Y; Suzuki H; Kamide D; Tomifuji M; Uno K; Kimura E; Yamashita T; Ueda Y; Shiotani A
Mol Cancer Ther; 2019 Aug; 18(8):1430-1438. PubMed ID: 31171582
[TBL] [Abstract] [Full Text] [Related]
14. Circulating upa as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma.
He X; Xu X; Zhu G; Ye H
Medicine (Baltimore); 2019 Mar; 98(9):e14717. PubMed ID: 30817615
[TBL] [Abstract] [Full Text] [Related]
15. Expression of urokinase-type plasminogen activator and its receptor in squamous cell carcinoma of the oral tongue.
Serpa MS; Mafra RP; Queiroz SIML; Silva LPD; Souza LB; Pinto LP
Braz Oral Res; 2018; 32():e93. PubMed ID: 30231175
[TBL] [Abstract] [Full Text] [Related]
16. XBP1 promotes tumor invasion and is associated with poor prognosis in oral squamous cell carcinoma.
Sun Y; Jiang F; Pan Y; Chen X; Chen J; Wang Y; Zheng X; Zhang J
Oncol Rep; 2018 Aug; 40(2):988-998. PubMed ID: 29916547
[TBL] [Abstract] [Full Text] [Related]
17. TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling.
Zhang B; Zhang Z; Li L; Qin YR; Liu H; Jiang C; Zeng TT; Li MQ; Xie D; Li Y; Guan XY; Zhu YH
Nat Commun; 2018 Apr; 9(1):1423. PubMed ID: 29650964
[TBL] [Abstract] [Full Text] [Related]
18. Diallyl disulfide inhibits the metastasis of type Ⅱ esophageal‑gastric junction adenocarcinoma cells via NF-κB and PI3K/AKT signaling pathways in vitro.
Yin X; Feng C; Han L; Ma Y; Jiao Y; Wang J; Jia L; Jing F; Gao X; Zhang Y; Zhang J
Oncol Rep; 2018 Feb; 39(2):784-794. PubMed ID: 29207122
[TBL] [Abstract] [Full Text] [Related]
19. Anticancer Effects of Colchicine on Hypopharyngeal cancer.
Cho JH; Joo YH; Shin EY; Park EJ; Kim MS
Anticancer Res; 2017 Nov; 37(11):6269-6280. PubMed ID: 29061810
[TBL] [Abstract] [Full Text] [Related]
20. Cleavage of the urokinase receptor (upaR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract] [Full Text] [Related]
[Next]